TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 149.00
-1.50 (-1.00%)
Sep 8, 2026, 1:30 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 9.9 billion as of September 4, 2026. Its market cap has increased by 65.97% in one year.
Market Cap
9.90B
Enterprise Value
8.72B
Revenue
701.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
149.00
ChartMarket Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 9.90B, an increase of 623.56%. That is a compound annual growth rate of 14.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 9.90B | -3.10% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 14.35B |
| Lumosa Therapeutics | 13.35B |
| ACRO Biomedical | 12.43B |
| AP Biosciences | 9.27B |
| Polaris Group | 8.90B |
| Tanvex BioPharma | 8.40B |
| PharmaEngine | 8.30B |
| Locus Cell | 8.09B |